Caspase-9 is an initiator caspase that mediates apoptosis induced by cytotoxic agents. Cardone et al. (1) reported that Akt, a kinase that suppresses apoptosis, phosphorylates caspase-9, thereby preventing activation of this protease. This finding is of fundamental importance because it explains how growth factors can prevent cell death and because it demonstrates that caspases, a central part of the apoptotic machinery, can be regulated by phosphorylation.
Given that importance, we tried to establish a reason for our failure to detect phosphorylated caspase-9 in cell lines we have analyzed. In particular, we decided to test, using a functional assay, whether caspase-9 is regulated by Akt phosphorylation. We planned to reintroduce caspase-9 or its Akt phosphorylation site mutants into cells derived from mice deficient in caspase-9. We reasoned that the lack of endogenous caspase-9 would allow unambiguous detection of the mutations' effect.
The experiment remained unfinished, however, because we found that mouse caspase-9 had no Akt phosphorylation sites, despite the close similarity between human and mouse proteins (Fig. 1) . Subsequently, we found that Akt phosphorylation sites were also absent in caspase-9 obtained from MDCK cells, a dog kidney cell line used by Cardone et al. (1) to make the original observation. Hence, Akt can phosphorylate caspase-9 in neither mice nor dogs. Such a variability among species runs counter to the observation that the Akt phosphorylation site in Bad-a protein that is involved in apoptosis and is regulated by Akt-is conserved from zebrafish to humans. Either it must be assumed that Akt regulates apoptosis differently in mice and humans, or the notion that caspase-9 is regulated by Akt phosphorylation has to be reexamined.
Joe in vitro. The observation that shorter-lived lower mammals lack the Akt phosphorylation site in caspase-9 suggests that this phosphorylation site evolved relatively recently in humans, providing an additional way of regulating the cytochrome c pathway that couples mitochondrial damage to caspase activation. Though the absence of consensus Akt phosphorylation sequences in caspase-9 of shorter-lived mammals is interesting, it does not detract from the significance of our findings (2). Our work provided the first example of protease regulation by phosphorylation, which reveals a novel paradigm for modulating the activity of proteases in cells. Defects in the pathways regulating Akt have been documented in a large proportion of human cancers; our data showed that in human tumor cell lines, Akt-mediated phosphorylation of caspase-9 represents one mechanism used by Akt to suppress apoptosis. Thus, although the findings of Rodriguez et al. argue against a role for caspase-9 phosphorylation in normal, evolutionarily conserved processes (such as fetal development) in which programmed cell death is important, they do not exclude a role in humans for either too much or too little Akt-mediated phosphorylation of caspase-9 in pathologies (such as cancer or neurodegenerative diseases) where cell accumulation or cell death occurs.
All analysis of caspase-9 phosphorylation was performed in human cell lines, rather than rodent or canine cells, and we stand by those data (2) . Also, in the experiments involving cytosolic extracts from murine and canine cell lines transfected with active Akt or Ki-Ras (which is known to cause Akt activation), we added in vitro translated human pro-caspase-9 and monitored cytochrome c-induced processing and activation of human pro-caspase-9 in vitro. Our published data, however, also revealed a suppression of cytochrome c-inducible effector caspase activity in cytosolic extracts prepared from murine and canine cells with elevated Akt activity (2) . These data, together with the apparent absence of consensus Akt phosphorylation sites for mouse and dog caspase-9, imply the existence of an additional, evolutionarily conserved mechanism by which Akt can suppress activation of caspases in the cytochrome c (mitochondrial) pathway for apoptosis. Candidates for this target of Akt regulation might include caspase-9 activators, particularly Apaf-1 (3); caspase-9 suppressors such as XIAP (4); unidentified proteins that modulate the cytochrome c/Apaf-1 apoptosome; and downstream caspases such as caspase-7, which contains a candidate Akt phosphorylation site (RxRxxT) that is conserved in both mice and humans. 
